Samsung Medison announced the completion of its acquisition of French startup Sonio, a move that underscores the company’s commitment to integrating artificial intelligence (AI) into medical devices. The acquisition, which closed on August 30, marks an important milestone in Samsung Medison’s strategy to improve the accessibility and accuracy of medical services globally.
Sonio, known for its expertise in ultrasound diagnostic reporting and AI diagnostic assistance, is bringing its advanced AI solution “Detect,” which evaluates the quality of ultrasound images in real time. This acquisition is part of Samsung Medison’s broader strategy to secure cutting-edge technology in medical devices and introduce solutions that leverage AI and computing.
A Samsung Medison representative emphasized the company’s focus on simplifying healthcare professionals’ workflow and innovating in the accessibility and accuracy of medical services. “The acquisition of Sonio is a strategic move to further strengthen this focus,” the representative said.
Yu Kyoo-tae, CEO of Samsung Medison, highlighted the potential impact of Sonio’s AI solutions on global healthcare. “Sonio’s AI solution will significantly contribute to bridging the gap in areas where skilled medical professionals in imaging diagnosis are lacking, enabling the delivery of high-quality medical services worldwide,” Yu said. “We will lead the innovation in the accessibility and accuracy of medical devices by combining Samsung’s technology with Sonio’s AI solutions.”
Samsung Medison, a subsidiary of Samsung Electronics, has been a major player in the medical technology sector since its establishment in 1985. The company is renowned for integrating cutting-edge technologies into healthcare solutions, particularly in the field of ultrasound imaging systems. Ultrasound imaging is an essential diagnostic tool used in various medical fields, and recent advances have focused on improving image quality and diagnostic accuracy through the integration of AI.
The role of AI in healthcare has been transformative, improving diagnostic accuracy, streamlining workflows, and providing decision support. AI algorithms can analyze medical images, predict patient outcomes, and help develop personalized treatment plans, mitigating human error and improving the efficiency of healthcare professionals.
Global health disparities remain a pressing issue, with many regions lacking access to skilled healthcare professionals and advanced diagnostic tools. Innovations such as AI-assisted ultrasound imaging can help bridge this gap by providing high-quality diagnostics in underserved areas. The acquisition of Sonio enables Samsung Medison to address these disparities by leveraging AI to deliver high-quality medical services globally.
